Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Leukemia, Myelogenous, Chronic, BCR-ABL Positive × Bendamustine Hydrochloride × 90 days × Clear all

Sponsor

Conditions

Leukemia, Lymphocytic, Chronic, B-Cell 10 Lymphoma, Follicular 8 Lymphoma 8 Lymphoma, Mantle-Cell 5 Neoplasms 3 Lymphoma, Non-Hodgkin 3 Lymphoma, Large B-Cell, Diffuse 3 Lymphoma, B-Cell 3 Recurrence 2 Lymphoma, B-Cell, Marginal Zone 2 Leukemia 2 Hodgkin Disease 2 Waldenstrom Macroglobulinemia 1 Sezary Syndrome 1 Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 1 Ovarian Neoplasms 1 Mycosis Fungoides 1 Multiple Myeloma 1 Lymphoproliferative Disorders 1 Lymphomatoid Papulosis 1 Lymphoma, T-Cell, Peripheral 1 Lymphoma, T-Cell, Cutaneous 1 Lymphoma, T-Cell 1 Lymphatic Diseases 1 Immunoproliferative Disorders 1 Immunoblastic Lymphadenopathy 1 Immune System Diseases 1 Hematopoietic and Lymphoid System Neoplasm 1 Hematologic Diseases 1 Fallopian Tube Neoplasms 1

Interventions

Cyclophosphamide 11 fludarabine 10 fludarabine phosphate 8 asciminib 7 Whole-Body Irradiation 7 Mycophenolic Acid 7 Tacrolimus 6 Melphalan 5 Busulfan 5 nilotinib 4 Mesna 4 Granulocyte Colony-Stimulating Factor 4 Dasatinib 4 Imatinib Mesylate 3 Filgrastim 3 olverembatinib 2 bosutinib 2 Thiotepa 2 Stem Cell Transplantation 2 Peripheral Blood Stem Cell Transplantation 2 Patient Reported Outcome Measures 2 Magnetic Resonance Spectroscopy 2 Cyclosporine 2 Bone Marrow Transplantation 2 venetoclax 1 treosulfan 1 thymoglobulin 1 ruxolitinib 1 ponatinib 1 blinatumomab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡